Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD finger protein 10 (PHF10) is a subunit of the polybromo-BAF (PBAF) subclass of the mammalian SWI/SNF chromatin remodeling complex, notable for harboring a distinctive C-terminal tandem PHD finger domain and an N-terminal SAY domain[1][2]. PHF10 exists as evolutionarily conserved isoforms, one with C-terminal PHD fingers and another with a phosphorylation-dependent SUMO 1 conjugation motif, and each isoform confers tissue-specific functional diversity to PBAF complexes in transcriptional regulation[2]. PHF10 is required for tissue-specific chromatin accessibility, neural progenitor differentiation, osteogenic and odontogenic maturation, and cell proliferation[1][2][3]. Depletion or genetic deficiency of PHF10 leads to impaired differentiation in neural, hematopoietic, and mineralizing tissues (bone, tooth)[1][2]. It is regarded as a critical epigenetic regulator, and its dysfunction is implicated in oncogenesis and developmental disorders through effects on gene expression and cellular differentiation[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD finger protein 10 (PHF10).